Felipe Salech

Felipe Salech

Auto-generated profile, based on publicly available information

Felipe Salech

Unidad de Geriatría, Hospital Clínico Universidad de Chile, Santiago, Chile

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2006 in Journal of Clinical Gastroenterology
Verified
Journal Article
Closed access
ARArnoldo Riquelme
Arnoldo Riquelme
MCMario Calvo
Mario Calvo
FSFelipe Salech
Felipe Salech
SVSebastián Valderrama
Sebastián Valderrama
APAlejandro Pattillo
Alejandro Pattillo
LLLuz María Letelier
Luz María Letelier
Adenosine deaminase (ADA) levels are used for diagnosing tuberculosis in several locations and although many studies have evaluated ADA levels in ascitic fluid. These studies have defined arbitrary cut-off points creating difficulties in the clinical application of the results. The goals of this study are: to determine the usefulness of ADA levels in ascitic fluid as a diagnostic test for peritoneal tuberculosis (PTB) and define the best cut-off point. A systematic review was done on the basis of 2 independent searches. We selected prospective studies that included consecutive patients. Diagnosis of PTB had to be confirmed by bacteriologic or histologic methods and ADA levels determined by the Giusti method. Inclusion/exclusion criteria were applied by 2 independent reviewers. A receiver operating characteristic curve was constructed to establish the optimal cut-off point and the likelihood ratios (LRs) estimated using fixed-effect pooled method. Twelve prospective studies were found. Four of them met the inclusion criteria and were thus included in the meta-analysis. They included 264 patients, of which 50 (18.9%) had PTB. ADA levels showed high sensitivity (100%) and specificity (97%) using cut-off values from 36 to 40 IU/L. The included studies were homogeneous. Optimal cut-off point was determined at 39 IU/L, and LRs were 26.8 and 0.038 for values above and below this cut-off. This study supports the proposition that ADA determination is a fast and discriminating test for diagnosing PTB with an optimal cut-off value of 39 IU/L.

15 March 2016 in Molecular Brain
Verified
Journal Article
Open access
PDF file
MMMuriel D. Mardones
Muriel D. Mardones
GAGabriela A. Andaur
Gabriela A. Andaur
MVManuel Varas-Godoy
Manuel Varas-Godoy
JHJenny F. Henriquez
Jenny F. Henriquez
FSFelipe Salech
Felipe Salech
LVLorena Varela-Nallar
Lorena Varela-Nallar
In the adult hippocampus new neurons are continuously generated from neural stem cells (NSCs) present at the subgranular zone of the dentate gyrus. This process is controlled by Wnt signaling, which plays a complex role in regulating multiple steps of neurogenesis including maintenance, proliferation and differentiation of progenitor cells and the development of newborn neurons. Differential effects of Wnt signaling during progression of neurogenesis could be mediated by cell-type specific expression of Wnt receptors. Here we studied the potential role of Frizzled-1 (FZD1) receptor in adult hippocampal neurogenesis. In the adult dentate gyrus, we determined that FZD1 is highly expressed in NSCs, neural progenitors and immature neurons. Accordingly, FZD1 is expressed in cultured adult hippocampal progenitors isolated from mouse brain. To evaluate the role of this receptor in vivo we targeted FZD1 in newborn cells using retroviral-mediated RNA interference. FZD1 knockdown resulted in a marked decrease in the differentiation of newborn cells into neurons and increased the generation of astrocytes, suggesting a regulatory role for the receptor in cell fate commitment. In addition, FZD1 knockdown induced an extended migration of adult-born neurons within the granule cell layer. However, no differences were observed in total dendritic length and dendritic arbor complexity between control and FZD1-deficient newborn neurons. Our results show that FZD1 regulates specific stages of adult hippocampal neurogenesis, being required for neuronal differentiation and positioning of newborn neurons into the granule cell layer, but not for morphological development of adult-born granule neurons.

Verified
Journal Article
Open access
PDF file
FSFelipe Salech
Felipe Salech
CSCarol D SanMartín
Carol D SanMartín
JCJorge Concha-Cerda
Jorge Concha-Cerda
EREsteban Romero
Esteban Romero
DPDaniela Paz Ponce
Daniela Paz Ponce
MBMaría Isabel Behrens
María Isabel Behrens
Recent studies suggest that cellular senescence plays a role in Alzheimer’s Disease (AD) pathogenesis. We hypothesize that cellular senescence markers might be tracked in the peripheral tissues of AD patients. Senescence hallmarks, including altered metabolism, cell-cycle arrest, DNA damage response (DDR) and senescence secretory associated phenotype (SASP), were measured in peripheral blood mononuclear cells (PBMCs) of healthy controls (HC), amnestic mild cognitive impairment (aMCI) and AD patients. Senescence-associated βeta-galactosidase (SA-β-Gal) activity, G0-G1 phase cell-cycle arrest, p16 and p53 were analyzed by flow cytometry, while IL-6 and IL-8 mRNA were analyzed by qPCR, and phosphorylated H2A histone family member X (γH2AX) was analyzed by immunofluorescence. Senescent cells in the brain tissue were determined with lipofuscin staining. An increase in the number of senescent cells was observed in the frontal cortex and hippocampus of advanced AD patients. PBMCs of aMCI patients, but not in AD, showed increased SA-β-Gal compared with HCs. aMCI PBMCs also had increased IL-6 and IL8 mRNA expression and number of cells arrested at G0-G1, which were absent in AD. Instead, AD PBMCs had significantly increased p16 and p53 expression and decreased γH2Ax activity compared with HC. This study reports that several markers of cellular senescence can be measured in PBMCs of aMCI and AD patients.

9 February 2011
Verified
Journal Article
Closed access
FSFelipe Salech
Felipe Salech
SVSebastián Valderrama
Sebastián Valderrama
BNBruno Nervi
Bruno Nervi
JRJuan Carlos Rodriguez
Juan Carlos Rodriguez
DODanny Oksenberg
Danny Oksenberg
ARArnoldo Riquelme
Arnoldo Riquelme

29 April 2009
Verified
Journal Article
Closed access
ARArnoldo Riquelme
Arnoldo Riquelme
MOMacarena Oporto
Macarena Oporto
JOJorge Oporto
Jorge Oporto
JMJosé Ignacio Méndez
José Ignacio Méndez
PVPaola Viviani
Paola Viviani
ISIgnacio Sánchez
Ignacio Sánchez

30 December 2017 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
FSFelipe Salech
Felipe Salech
LVLorena Varela-Nallar
Lorena Varela-Nallar
SASebastián B Arredondo
Sebastián B Arredondo
DBDaniel B Bustamante
Daniel B Bustamante
GAGabriela A Andaur
Gabriela A Andaur
ACAndrés Couve
Andrés Couve
Klotho is an aging-related protein associated with hippocampal cognitive performance in mammals. Klotho regulates progenitor cell proliferation in non-neuronal tissues, but its role in adult hippocampal neurogenesis (AHN) has not been explored. Klotho expression in the adult mouse hippocampus was examined by immunofluorescence and PCR. AHN was evaluated in the hippocampus of klotho knock-out mice (KO), klotho KO/vitamin D-receptor mutant mice, and in a model of local klotho hippocampal knockdown. The recombinant Klotho effect on proliferation was measured in mouse-derived hippocampal neural progenitor cells. Hippocampal-dependent memory was assessed by a dry-land version of the Morris water maze. Klotho was expressed in the granular cell layer of the adult Dentate Gyrus. AHN was increased in klotho KO mice, but not in klotho KO/vitamin D-receptor mutant mice. Inversely, local downregulation of hippocampal Klotho diminished AHN. Recombinant Klotho increased the proliferation rate of neural progenitors. Downregulation of hippocampal Klotho correlated with a decreased performance in hippocampal dependent memory. These results suggest that Klotho directly participates in regulating AHN. Our observations indicate that Klotho promotes proliferation, AHN and hippocampal dependent cognition. Increased neurogenesis in klotho KO mice may be secondary to the activation of other pathways altered in the model, such as vitamin D.